Wednesday, July 8, 2026

pharma · Cystic Fibrosis · Rheumatoid Arthritis · LKFT

Lakefront Biotherapeutics NV

LAVA Therapeutics N.V is a pharma organization headquartered in Utrecht, NL. It trades on NYSE under ticker LKFT. Primary therapeutic focus areas include Cystic Fibrosis, Rheumatoid Arthritis, Ulcerative Colitis, Idiopat

Yalelaan 60, 5th floor, Utrecht 3584 CM, NL HQ
2016 Founded
9 Employees
Public company Type
LKFT · NYSE Ticker
Company details
Status
Public
HQ
Yalelaan 60, 5th floor, Utrecht 3584 CM, NL
Founded
2016
Employees
9
Programs
99
Drugs
26
Patents
0
Clinical program

Filgotinib

Approved · small molecule · Rheumatoid Arthritis

Filgotinib for Rheumatoid Arthritis is a Approved program (small_molecule) at Lakefront Biotherapeutics NV with 8 ClinicalTrials.gov record(s).

Internal code GLPG0634-CL-227

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Lakefront Biotherapeutics NV
Phase
Approved
Modality
small_molecule
Indication
Rheumatoid Arthritis
Status
active
Trials
8